Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Posted Basic Consolidated EPS Of $13.0018

0

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) annual basic consolidated EPS was $13.0018 for the period ended 2015-12-31. The basic consolidated EPS was $13.0018 for the quarter ended 2015-12-31.

EPS from continuing operations

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)’s basic EPS from continuing operations was $13 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $13

EPS contribution from parent

From the parent company Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) posted basic EPS of $13.0018 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $13.0018.

Basic net EPS

The Basic net EPS of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) was $13 for the period ended 2015-12-31. The figure stood at $13 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $12.121. While the figure for the quarter ended 2015-12-31 stood at $12.121.

Basic diluted EPS

The diluted EPS from continuing operation of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) stood at $12.12 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $12.12

Net diluted EPS

The Net diluted EPS was $12.12 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $12.12.

Diluted EPS from parent

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) diluted EPS from the parent company for the fiscal 2015-12-31 was $12.121. The figure for the quarter ended 2015-12-31 was $12.121

The net basic EPS was $13 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $13.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 4 times, 1 visits today)